- Half Year 2023 Mithra Pharmaceuticals SA Earnings Call TranscriptSep 26, 2023€1.77 (-15.00%)Earnings
- Q4 2022 Mithra Pharmaceuticals SA Earnings Call TranscriptMar 07, 2023€3.09 (+13.39%)Earnings
- Mithra Pharmaceuticals SA and Richter Gedeon Vegyeszeti Gyar Nyrt to Discuss Partnership for the Commercialisation of Donesta Presentation TranscriptDec 20, 2022
- Q2 2022 Mithra Pharmaceuticals SA Earnings Call TranscriptSep 23, 2022€6.6 (+2.96%)Earnings
- Full Year 2021 Mithra Pharmaceuticals SA Earnings Call TranscriptMar 08, 2022€13.7 (-12.85%)Earnings
- Mithra Pharmaceuticals SA to Discuss Donesta Top-Line Results Call TranscriptJan 14, 2022
- Half Year 2021 Mithra Pharmaceuticals SA Earnings Call TranscriptSep 24, 2021€17.8 (-3.78%)Earnings
- Full Year 2020 Mithra Pharmaceuticals SA Earnings Call TranscriptMar 09, 2021€23.4 (+9.35%)Earnings
- Half Year 2020 Mithra Pharmaceuticals SA Earnings Call TranscriptSep 24, 2020€16.86 (-1.29%)Earnings
- Mithra Pharmaceuticals SA at Jefferies Healthcare Conference (Virtual) TranscriptJun 03, 2020
Half Year 2023 Mithra Pharmaceuticals SA Earnings Call Transcript
Hello, and welcome to the Mithra Half Year Results 2023. My name is Jess, and I'll be your coordinator for today's event. Please note, this call is being recorded. (Operator Instructions)
I will now hand over to your host, Alex Sokolowski, Head of Investor Relations, to begin today's call. Thank you.
Thank you, operator and welcome, ladies and gentlemen, to the conference call on Mithra Pharmaceuticals' financial results for the first 6 months of 2023. I'm Alex Sokolowski, Head of Investor Relations for Mithra. Today's call is being recorded and a replay of this webcast and today's presentation slides will be made available later today on Mithra's website.
I'd like to call your attention to the forward-looking statements before I provide an overview of our agenda. Today's call contains forward-looking statements, which are made based on information currently available to Mithra and certain assumptions considered reasonable as of the date of this material. These forward-looking statements are not guarantees of future performance and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)